Clinical analysis of MOG antibody-associated disease overlapped with anti-NMDA receptor encephalitis: a long-term retrospective study
Tianjiao Duan1,2, Song Ouyang3,4, Zhaolan Hu5, Qiuming Zeng6, Weifan Yin1,2,4*
1 Department of Neurology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China
2 Clinical Medical Research Center for Stroke Prevention and Treatment of Hunan Province, Department of Neurology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China
3 Department of Neurology, the affiliated Changsha Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, P.R. China
4 The “Double-First Class” Application Characteristic Discipline of Hunan Province (Clinical Medicine), Changsha Medical University, Changsha, Hunan, P.R. China
5 Department of Anesthesiology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China
6 Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China
* Correspondence to:
Weifan Yin, M.D., Ph.D.
Department of Neurology, The Second Xiangya Hospital, Central South University, No. 139 Middle Renmin Road, Changsha, Hunan 410011, P.R. China
Email: yinweifan1985@csu.edu.cn
Keyword: myelin oligodendrocyte glycoprotein (MOG), MOG antibody–associated disease, NMDAR encephalitis, MOG antibodies and anti-NMDAR encephalitis overlapping syndrome.